Grace Therapeutics GAAP EPS of -$0.14 beats by $0.14
Source: SeekingAlpha
2026-02-12 08:14:04 ET
More on Grace Therapeutics
- Seeking Alpha’s Quant Rating on Grace Therapeutics
- Historical earnings data for Grace Therapeutics
- Financial information for Grace Therapeutics
Read the full article on Seeking Alpha
For further details see:
Grace Therapeutics GAAP EPS of -$0.14 beats by $0.14
Grace Therapeutics Inc.
NASDAQ: GRCE
GRCE Trading
-5.15% G/L:
$2.32 Last:
105,312 Volume:
$2.38 Open:
GRCE Latest News
May 27, 2026 11:33:00 am
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
April 23, 2026 01:13:24 pm
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
GRCE Stock Data
$50,750,823
10,912,118
1.33%
19
N/A
Biotechnology & Life Sciences
Healthcare
CA
Princeton
